drugset
Drugs / TA-CD
last change Jul 2014 re-read 3 minutes ago

TA-CD

Vaccine

Developed for
cocaine dependence
Investigated by
Baylor College of Medicine · Celtic Pharma Development Services · Columbia University · Johns Hopkins University · National Institute on Drug Abuse (NIDA) · US Department of Veterans Affairs Cooperative Studies Program
+4 more · University of Cincinnati · University of Pennsylvania · VA Maryland Health Care System · VA New York Harbor Healthcare System

Trials 1

today NCT00969878 · Ph 2
20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00969878 Aug 2010 → Aug 2012 cocaine dependence Baylor College of Medicine Completed Missed primary

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TA-CD ClinicalTrials.gov intervention name — accepted as the source's own label NCT00969878 ↗
Modality Vaccine “The purpose of this study is to test the efficacy of a newly developed active vaccine against cocaine (TA-CD).” NCT00969878 ↗
Route Intramuscular “TA-CD 400 μg will be administered intramuscular.” NCT00969878 ↗